OMEZA
omeza.com
Actively hiring
Wound Care
Health Care
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$26.7M
7 rounds on record
Latest round
$8.5M
Series A · Apr 2026 · 5 mo ago
Team
51-200
employees, estimated range
Backers
1
Florida Opportunity Fund
The money's age
Fresh money
5 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 13
Recognition OMEZA LLC Named No. 230th on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America's Fastest-Growing Private Companies · streetinsider.com
Apr 21
Raised a round Series A $8.5M · led by Astanor · The Globe and Mail
Dec 19, 2024
Raised a round Venture round $906k · SEC Form D
Jun 16, 2023
Raised a round Venture round $6.5M · SEC Form D
Nov 30, 2022
Took on debt financing $1.6M · SEC Form D
Feb 11, 2022
Took on debt financing $4.8M · SEC Form D
Mar 3, 2021
Raised a round Convertible Note $5M · SEC Form D
Mar 28, 2019
Raised a round Venture round $5.8M · SEC Form D
2014
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Apr 2026 | $8.5M | Astanor lead, Blukap Ventures lead, Catalyst Investments | The Globe and Mail |
| Venture round | Dec 2024 | $906k | — | SEC Form D |
| Venture round | Jun 2023 | $6.5M | — | SEC Form D |
| Debt Financing | Nov 2022 | $1.6M | — | SEC Form D |
| Debt Financing | Feb 2022 | $4.8M | — | SEC Form D |
| Convertible Note | Mar 2021 | $5M | — | SEC Form D |
| Venture round | Mar 2019 | $5.8M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Omeza, LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Thomas GardnerExecutive Officer, DirectorSEC Form D
Cynthia FlowersExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Florida Opportunity Fund News
OMEZA Holdings announces new partnership with Spartan Medical
The new exclusive partnership opens access to OMEZA
Read more
Report
OMEZA's OCM will be featured in an approved abstract treating a complex chronic burn patient at Fall SAWC Oct.15-18 in Las Vegas
Read more
Report
OMEZA LLC Named No. 230th on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America's Fastest-Growing Private Companies
Read more
Report
Omeza Announces Closing of $8.5 Million Series a Financing Co-Led by Astanor and Blukap Ventures, With Participation From Catalyst Investments
Round positions Omeza to accelerate clinical development and scale nationwide commercialization of its FDA-cleared regenerative wound care platform SARASOTA, FL / ACCESS Newswire / April 21, 2026 /Omeza Holdings, Inc. ("Omeza"), a commercial-stage ...
Read more
Report
Omeza Announces Closing of $8.5 Million Series a Financing Co-Led by Astanor and Blukap Ventures, With Participation From Catalyst Investments
ACCESS Newswire Press Release.
Read more
Report
OMEZA CLINICAL STUDY TO EVALUATE OCM WOUND MATRIX FOR THE TREATMENT OF CHRONIC CUTANEOUS WOUNDS/ULCERS OF MULTIPLE ETIOLOGIES HAS COMPLETED ...
Read more
Report
NOVEL OMEZA OCM WOUND MATRIX CLINICAL STUDY IN VENOUS LEG ULCERS HAS COMPLETED ENROLLMENT AND FINAL DATABASE LOCK. FULL RESULTS TO BE SUBMITTED ...
Read more
Report
People
Thomas Gardner
Executive Officer, Director
Cynthia Flowers
Executive Officer, Director
Joel Morganroth
Director
Ag Lafley
Director
Ronald Gelbman
Director
Robert Essner
Director
Richard Hague
Director
Frank Martuci
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Sarasota
United States
HQ
50-200 est. staff
Financials
Total raised
$33.1M
Latest round
Series A
Funding rounds
7